Phico Therapeutics

About:

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

Twitter/X: phicotx

Top Investors: Innovate UK, Wellcome Trust, 24 Haymarket, Business Growth Fund, Winton Ventures

Description:

Phico Therapeutics is a biotechnology company developing a novel platform technology which it believes could form the basis for a new generation of antibiotics to overcome antibacterial resistance.

Total Funding Amount:

$41M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2000-01-01

Contact Email:

info(AT)phicotherapeutics.co.uk

Founders:

Heather Fairhead

Number of Employees:

1-10

Last Funding Date:

2021-05-11

IPO Status:

Private

Industries: